Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-4-1
pubmed:abstractText
Use of intracoronary calcium channel blockers (CCBs) during percutaneous coronary intervention (PCI) has been shown to have favorable effects on coronary blood flow. We aimed to investigate the effects of CCBs administrated perorally on creatine kinase-MB (CK-MB) levels in patients undergoing elective PCI.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-10413641, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-10618560, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-10889126, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-11244022, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-11723019, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-11827918, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12042618, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12181228, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12390944, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12551866, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12558122, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12660661, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-12771007, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-15120048, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-15193674, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-15277322, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-15812827, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-1671346, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-2488097, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-8353912, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-8840840, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-8989153, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-9237030, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-9462562, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-9488202, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-9672272, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337554-9935014
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1178-2048
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1417-22
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.
pubmed:affiliation
Baskent University Faculty of Medicine, Department of Cardiology, Oymaci sokak No: 7, Altunizade, Istanbul, Turkey. gulmezoyku@yahoo.com
pubmed:publicationType
Journal Article